BFS stock price has increased ~20% in last 5 days, does anyone know what is going on? Cannot find any news or announcements around it.
Posts tagged Value Pickr
Smallcap momentum portfolio (22-06-2024)
@visuarchie sir, the Z-score strategy was not included in the pure momentum strategy because it is often considered more of a statistical method used to identify overbought or oversold conditions rather than a primary momentum strategy. Most momentum strategies focus on trend following and relative strength, which are easier to understand and implement for many investors.
As you know Z-score Strategy measures how far a data point (stock price) is from the mean, expressed in terms of standard deviations. A high Z-score might indicate overbought conditions, while a low Z-score suggests oversold conditions.
- This strategy can help identify potential reversals rather than pure momentum plays.
In contrast, traditional momentum strategies like trend following, relative momentum, and sector rotation are more directly aligned with the core concept of momentum investing, which is capitalizing on stocks that are already trending upward or downward.
For those interested in momentum investing, combining the Z-score with other momentum strategies might offer additional insights and enhance overall performance. The Z-score can act as a complementary tool to identify extremes and potential mean-reversion points within a broader momentum framework.
Your input please, why not other strategy than z score which you follow, please.
Shankara Build Pro – Building Materials Organised Retail (22-06-2024)
I was going through the Annual Report 23-24 consolidated P/L statement and found that there is an interest expense of 27Cr. while total borrowing of the company is only 83Cr. as per consolidated Balance Sheet. This amounts to around 32% cost of borrowings annually, similar to credit cards! I could not find any explanation regarding high interest expense by going through the notes. Is this really correct or am I missing something?
Antony Waste – Long Term (22-06-2024)
Likely Deducted from Deferred Tax Asset. Company had paid extra tax in the past, they’re deducting it now.
Jagsonpal Pharmaceuticals – What is driving the price? (22-06-2024)
Just want to share few points which may be relevant in the future of this company :-
1 Mr Manish Gupta, Md had purchased 1.62 % equity of the company in Feb 2022 ie before joining the company as MD @ Rs 235/share… He joined as MD in Aug 22.
2 May be Mr Manish Gupta was instrumental in Purchase of 43% shares by the Infinity Holding arond the same price.
3 Yash pharma acquired by JPL at 2 times P/S which has given exposure to Derma and childcare. Sharing the link of the presentation about both the companies.
Hope to see good growth in top line and the margins keeping in view the past track record of MD.
https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4e8819fe-ac27-486d-a702-78c42da4ea1b.pdf
Annapurna Swadisht Ltd – A Swadisht FMCG investment? (22-06-2024)
ANNAPURNA_21062024195640_Intimation_under_Regulation_30.pdf (549.1 KB)
Preferential allotment of 6,00,000 shares @ Rs.295/-
Lazycap’s Portfolio – Feedback (22-06-2024)
Update
Entered GPT healthcare with 3.5% position on folio cost basis at 156. Seems like a good bet considering it is one the undervalued ones in Hospital. Good capex plans going ahead, will add more once convinced of prospects or thinking to play as a basket with likes of HCG/Aster/Shalby/Narayana
I like GPT though, I have not studied others much I just know them on the surface level, As GPT is already at medium cost basis for patients I am hoping if any regulations are enforced in terms of pricing of procedures at hospitals this one might turnout to be least affected (no numbers support as such just a though derived from what I saw in Management interviews)
Jagsonpal Pharmaceuticals – What is driving the price? (22-06-2024)
New product launch by Jagsonpal